Kidney Cancer DNA Registry
Conditions
Renal Cancer
Conditions: official terms
Carcinoma, Renal Cell - Kidney Neoplasms
Conditions: Keywords
Questionnaire, DNA, saliva, kidney cancer, 13-218
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control, Time Perspective: Prospective
Intervention
Name: salvia for germline DNA Type: Other
Name: the Kidney Cancer Questionnaire Type: Behavioral
Name: Family History Questionnaire (when applicable) Type: Behavioral
Overall Status
Recruiting
Summary
This registry will help us develop better methods of:

- Preventing these cancers

- Diagnosing these cancers

- Treating these cancers
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

Kidney Cancer Case Cohort:

- Must be ≥ 18 years of age AND

- Must be an English-speaker AND

- Must have a diagnosis or suspicion of kidney cancer

Family Member Cohort:

- Must be ≥ 18 years of age AND

- Must be an English-speaker AND

- Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required.

Control Cohort:

- Must be ≥ 18 years of age AND

- Must be an English-speaker AND

- Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND

- Must not be a blood relative of any cases or controls enrolled in this study

Exclusion Criteria:

- Patients who, in the opinion of the primary MSKCC clinician or the investigator, have a condition that precludes their ability to provide an informed consent
Location
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Status: Recruiting
Contact: Jonathan Coleman, MD - 646-422-4432
Start Date
March 2014
Sponsors
Memorial Sloan Kettering Cancer Center
Source
Memorial Sloan Kettering Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page